Thomas Rechtschaffen, MD, FACS

Thomas Rechtschaffen, MD, FACS

Castle Connolly Top Doctors

Board-Certified Urologist | Advanced Prostate Cancer Specialist

Dr. Thomas Rechtschaffen is a highly experienced urologist specializing in prostate health, pelvic pain, and advanced diagnostic and treatment techniques. He leads the Advanced Urologic Cancer Center in Westchester, delivering cutting-edge, patient-centered care.

A lifelong resident of lower Westchester, Dr. Rechtschaffen has been in practice for more than 30 years, providing comprehensive urologic care with a strong focus on innovation and patient outcomes. He is currently leading the Advanced Urologic Cancer Center in Westchester, where he focuses on advanced prostate cancer diagnosis and treatment.

Dr. Rechtschaffen is committed to staying at the forefront of urology, incorporating emerging technologies such as Next Generation Sequencing (NGS) for urinary tract infections, MRI-fusion prostate biopsies, genomic and germline testing, and advanced nerve stimulation therapies for urinary conditions.

He is also widely recognized as one of the most experienced providers of the UroLift® procedure in the New York metropolitan area, offering patients a minimally invasive solution for enlarged prostate that preserves sexual function and allows for rapid recovery.

  • Prostate cancer diagnosis and advanced treatment
  • Benign prostatic hyperplasia (BPH)
  • Pelvic pain and interstitial cystitis
  • Recurrent urinary tract infections (UTIs)
  • Male infertility
  • Urinary frequency and voiding dysfunction
  • Minimally invasive urologic procedures
  • Advanced prostate cancer 
  • Enlarged prostate (BPH)
  • Prostate cancer
  • Interstitial cystitis
  • Chronic pelvic pain
  • Recurrent urinary tract infections
  • Male infertility
  • Urinary frequency and urgency
  • Voiding dysfunction
  • English 
  • American Board of Urology
  • American Urological Association (including national leadership roles) 

Dr. Rechtschaffen is actively engaged in advancing urologic care through the adoption of innovative diagnostic and treatment technologies, including genomic testing and MRI-fusion biopsy techniques.

Dr. Rechtschaffen has held multiple national leadership roles within the American Urological Association and has been actively involved in advocacy efforts on Capitol Hill, supporting physicians and improving patient care at a national level.